Biotech Cellectar Initiates Pivotal Trial of CLR 131 in Waldenstrom’s Macroglobulinemia January 12, 2021
Biotech Cocrystal Pharma to Present at Virtual NobleCon17 Conference on January 19, 2021 January 12, 2021
Biotech Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD January 12, 2021
Biotech ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – FBIO January 11, 2021
Biotech SHAREHOLDER DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm January 11, 2021
Biotech EyePoint Pharmaceuticals Provides Business Update and Preliminary Fourth Quarter and Full-Year 2020 Net Product Revenues January 11, 2021
Biotech DEADLINE ALERT for YY, LRN, and FBIO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders January 11, 2021
Search
Biotech
January 12, 2021
January 12, 2021
January 12, 2021
January 11, 2021
January 11, 2021
January 11, 2021
January 11, 2021
January 11, 2021
January 11, 2021
January 11, 2021
